Trulieve Cannabis Merely Obtained A Massive Worth Purpose Elevate From This Analyst

In a Nov. 6 report, Beacon Securities analyst Russell Stanley raised his objective worth on Trulieve Cannabis (Trulieve Cannabis Stock Quote, Chart, Info, Analysts, Financials CSE:TRUL) to C$20.00 from C$11.00, citing stronger working effectivity, improved stability sheet flexibility, and a re-rating of valuation multiples.

Stanley talked about the model new objective shows a greater 9x quite a few utilized to his fiscal 2026 Adjusted EBITDA estimate, up from 6x beforehand, amid enhancing investor sentiment and Trulieve’s “renewed improvement outlook heading into 2026.”

The company not too way back reported third-quarter outcomes that beat consensus and reaffirmed its fiscal 2025 working cash motion guidance of on the very least US$250-million, whereas moreover initiating the redemption of its US$368-million senior secured notes due October 2026.

For the third quarter, Trulieve posted revenue of US$288-million and Adjusted EBITDA of US$103-million (36% margin), ahead of Beacon’s forecast at US$88-million (31%) and the Highway at US$96-million (33%).

Stanley talked about the outcomes marked “a clear beat on margins and worth self-discipline,” noting that working payments had been down US$9-million year-over-year and that gross margins obtained right here in virtually one proportion stage above forecast. Revenue declined 5% sequentially, according to seasonal guidance, whereas modest year-over-year improvement mirrored contributions from new retailer openings, enlargement in Ohio’s adult-use market, and higher wholesale product sales.

Trulieve generated US$77-million in working cash motion throughout the quarter, aided by working capital modifications, and exited with US$449-million in cash and equivalents. Stanley talked about the company’s option to redeem its senior secured notes “underscores its balance-sheet vitality and operational flexibility,” together with that administration would possibly drawback as a lot as US$150-million in new debt counting on market conditions nevertheless “has no quick wish to take motion.”

Trulieve continues to play a primary place in Florida’s Good & Protected adult-use cannabis initiative, which had validated larger than 675,000 signatures as of Nov. 1 in the direction of the 880,000 required by February 2026. Stanley talked about the advertising marketing campaign stays on monitor for inclusion on the November 2026 ballot, with a stronger approved framework and a further helpful political setting than in 2024.

Stanley estimates Trulieve will generate US$1.19-billion in revenue and US$427-million in Adjusted EBITDA in fiscal 2025, adopted by US$1.20-billion and US$415-million in 2026. He well-known that Trulieve trades at 5.7x his 2026 Adjusted EBITDA forecast, a few 13% low value to the 6.6x frequent of its largest U.S. multi-state buddies.

“Potential catalysts embody completion of the phrase redemption, new M&A train, continued progress on Florida adult-use legalization, and fourth-quarter outcomes,” Stanley talked about.

-30-